Search Results - "Cagnot, C."

HCV eradication reduces the occurrence of major adverse cardiovascular events in hepatitis C cirrhotic patients: data from the prospective ANRS CO12 CirVir cohort by Cacoub, P, Nahon, P, Layese, R, Bourcier, V, Cagnot, C, Marcellin, P, Guyader, D, Pol, S, Larrey, D, Roudot-Thoraval, F, Audureau, E

Get full text

Identifying residual risk of hepatocellular carcinoma following hepatitis C virus eradication in compensated cirrhosis: decision-tree and random forest models developed in the French multicenter prospective ANRS CO12 CirVir cohort by Audureau, E, Bourcier, V, Layese, R, Cagnot, C, Marcellin, P, Guyader, D, Pol, S, Larrey, D, Roudot-Thoraval, F, Nahon, P

Get full text

Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co‐infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End‐Stage Liver Disease as Compared to HCV Mono‐infected Patients by Salmon‐Ceron, Dominique, Nahon, Pierre, Layese, Richard, Bourcier, Valérie, Sogni, Philippe, Bani‐Sadr, Firouze, Audureau, Etienne, Merchadou, Laurence, Dabis, François, Wittkop, Linda, Roudot‐Thoraval, Françoise

“…It is widely accepted that human immunodeficiency virus (HIV) infection is a risk factor for increased severity of hepatitis C virus (HCV) liver disease…”
Get full text

PS-032 - HCV eradication reduces the occurrence of major adverse cardiovascular events in hepatitis C cirrhotic patients: data from the prospective ANRS CO12 CirVir cohort by Cacoub, P., Nahon, P., Layese, R., Bourcier, V., Cagnot, C., Marcellin, P., Guyader, D., Pol, S., Larrey, D., Roudot-Thoraval, F., Audureau, E.

Get full text

PS-034 - Identifying residual risk of hepatocellular carcinoma following hepatitis C virus eradication in compensated cirrhosis: decision-tree and random forest models developed in the French multicenter prospective ANRS CO12 CirVir cohort by Audureau, E., Bourcier, V., Layese, R., Cagnot, C., Marcellin, P., Guyader, D., Pol, S., Larrey, D., Roudot-Thoraval, F., Nahon, P.

Get full text

Prognostic factors of survival in HIV/HCV co‐infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort by Gelu‐Simeon, Moana, Lewin, Maïté, Ostos, Maria, Bayan, Tatiana, Beso Delgado, Maria, Teicher, Elina, Layese, Richard, Roudot‐Thoraval, Françoise, Fontaine, Hélène, Sobesky, Rodolphe, Salmon‐Céron, Dominique, Samuel, Didier, Seror, Olivier, Nahon, Pierre, Meyer, Laurence, Duclos‐Vallée, Jean‐Charles, Petrov‐Sanchez, Ventzislava, Autran, Brigitte, Boufassa, Faroudy, Bourlière, Marc, Dominguez, Stéphanie, Hézode, Christophe, Pageaux, Georges‐Philippe, Poizot‐Martin, Isabelle, Roque‐Afonso, Anne‐Marie, Samri, Assia, Vittecoq, Daniel, Dabis, F, Winnock, M, Loko, A, Sogni, P, Benhamou, Y, Trimoulet, P, Izopet, J, Paradis, V, Spire, B, Carrieri, P, Katlama, C, Pialoux, G, Valantin, A, Bonnard, P, Poizot‐Martin, I, Marchou, B, Rosenthal, E, Garipuy, D, Bouchaud, O, Gervais, A, Lascoux‐Combe, C, Goujard, C, Lacombe, K, Duvivier, C, Vittecoq, D, Neau, D, Morlat, P, BaniSadr, F, Boufassa, F, Dominguez, S, Autran, B, Roque, M, Solas, C, Serfaty, L, Chêne, G, Costagliola, D, Zucman, D, Simon, A, Dominguez, S, Billaud, E, Miailhes, P, Devoto, J, Couffin‐Cadiergues, S, Nahon, P, Mahuas‐Bourcier, V, Zucman‐Rossi, J, Bedossa, P, Laurent, A, Layese, R, Durand‐Zaleski, I, Marche, P, Thibault, V, Guyader, D, Dharancy, S, Leroy, V, Vilgrain, V, Bonjour, M, Cagnot, C, Petrov‐Sanchez, V

“…Background & Aims HIV/HCV co‐infected patients with hepatocellular carcinoma (HCC) have poorer survival than HCV mono‐infected patients. We aimed to evaluate…”
Get full text

Safety of sofosbuvir‐based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study by Anty, R., Favre, G., Coilly, A., Rossignol, E., Houssel‐Debry, P., Duvoux, C., De Ledinghen, V., Di Martino, V., Leroy, V., Radenne, S., Kamar, N., Canva, V., D'Alteroche, L., Durand, F., Dumortier, J., Lebray, P., Besch, C., Tran, A., Canivet, C. M., Botta‐Fridlund, D., Montialoux, H., Moreno, C., Conti, F., Silvain, C., Perré, P., Habersetzer, F., Abergel, A., Debette‐Gratien, M., Dharancy, S., Esnault, V. L. M., Fougerou‐Leurent, C., Cagnot, C., Diallo, A., Veislinger, A., Danjou, H., Samuel, D., Pageaux, G.‐P., Duclos‐Vallée, J.‐C.

“…Summary Background In liver transplant recipients with hepatitis C virus recurrence, there is concern about renal safety of sofosbuvir‐based regimens. Changes…”
Get full text

Comportements alimentaires des patients atteints de cirrhose compensée et non compliquée : étude cas-témoins en Île-de-France by Buscail, C., Bourcier, V., Fezeu, L., Roulot, D., Brûlé, S., Ben Abdesselam, Z., Cagnot, C., Hercberg, S., Nahon, P., Ganne, N., Julia, C.

“…L’étude ALICIR est destinée à évaluer les comportements alimentaires chez des patients atteints de cirrhose compensée (d’origine virale et alcoolique) et leur…”
Get full text